世界の動物用ワクチン市場：動物疾患、技術、動物、地域別 - 動向および予測
Global Veterinary Vaccines Market Segmented by Animal diseases , by Technology, by Animal Type & by Geography - Trends and Forecast (2017 - 2022)
|発行||Mordor Intelligence LLP||商品コード||319396|
|出版日||ページ情報||英文 190 Pages
|世界の動物用ワクチン市場：動物疾患、技術、動物、地域別 - 動向および予測 Global Veterinary Vaccines Market Segmented by Animal diseases , by Technology, by Animal Type & by Geography - Trends and Forecast (2017 - 2022)|
|出版日: 2017年01月24日||ページ情報: 英文 190 Pages||
The global market for veterinary vaccines has been estimated at USD 11,083 million in 2014 and is projected to reach USD 19,021 million by 2020 at a CAGR of 9.42% during the forecast period from 2014 to 2021.
Global Veterinary Vaccines Market- Market Dynamics
Veterinary vaccines help to improve health and welfare of animals, increase production of livestock in a cost-effective manner and prevent transmission of diseases among animals and also to humans. Efficient animal production and better access to high-quality protein dramatically increase meat and egg production and contribute to greater economic outcome. Also, the rapid development of animal vaccines can play an effective role in controlling emerging diseases. Veterinary vaccines comprise only approximately 23% of the global market for animal health products.
There are several factors listed in the study that drive the growth of the global veterinary vaccines market. Some of them are:
Growing awareness of animal health
Increasing investments by government bodies and associations
Increased demand for animal protein, including milk, meat, eggs, and fish
Increased expenditure on health care of companion animals
Some of the factors restraining the market growth are:
Rising maintenance costs for storage of vaccines
Increasing adoption of vegetarian food in major economies owing to increasing risk of obesity and other chronic disorders
Persistent economic slowdown
The veterinary vaccines market is segmented on the basis of products, diseases, technologies, and regions. Based on product type, the market is categorized into companion animal vaccines, livestock vaccines, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines and other animal vaccines. The porcine vaccine is the largest sub-segment contributing to a major share of the market, whereas companion animal vaccines are the fastest growing segment due to the increasing prevalence of zoonotic diseases in humans and growing pet population. The technology segment includes live attenuated, inactivated, subunit, conjugate, toxoid, recombinant and DNA vaccines. Live attenuated vaccine technology is the major technology in the veterinary vaccines market. The disease type segment includes Rabies, Brucellosis, Leptospirosis, Influenza, Rift Valley fever, Newcastle disease, Nipah virus infection, Hendra virus infection, Porcine Reproductive and Respiratory Syndrome virus and Japanese encephalitis Q fever.
Based on geography, the market is segmented into North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW). The European region is the leading veterinary vaccine market, closely followed by the United States. Middle East, Brazil, Argentina, Mexico, Turkey, China, and India are lucrative markets for veterinary vaccines, owing to the growing demand for livestock, development of new products and favorable government initiatives.
The top 3 players in the veterinary vaccines market are Pfizer, Merck, and Sanofi-Aventis, based on the revenues they generate each year. Pfizer is the market leader in the veterinary vaccines market (by revenue) but Merck is the market leader in livestock vaccines market and Sanofi-Aventis is leading in the companion vaccines market. There have been a few mergers/acquisitions by the key players in the veterinary vaccines market to expand their product portfolio in order to top the global market. Ex: Pfizer acquiring Wyeth, which supposedly is the largest acquisition. The industry players have adopted certain growth strategies to excel in the veterinary vaccines market.
Some of the key players in the market are:
Ceva Animal Health, Inc.
Merial (Animal Health Division of Sanofi)
Key Deliverables in the Study
Market analysis for the veterinary vaccines market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the veterinary vaccines market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
2. Market Analysis
3. Market Dynamics
6. Company profiles